Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Rev Allergy Immunol ; 56(1): 110-118, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30269296

RESUMO

Dermatitis is one of the most common illnesses encountered by healthcare providers and the causes are numerous. Contact dermatitis is the form of dermatitis resulting from contact with the environment, and it may be either irritant or allergic in nature. Patch testing has been the gold standard for diagnosis of allergic contact dermatitis since its formal description over 100 years ago by Jadassohn. While this diagnostic tool may seem simple to us today, there are numerous potential points for error that the practitioner must keep in mind. Patient selection, technique of patch test placement, allergen selection, patch test reading and interpretation, and patient management all must be considered. To simply apply a given set of test allergens indiscriminately and not be prepared to interpret the results accurately with patient education and management in mind would be a great failure. Conversely, with experience and the proper knowledge base some of the most complex dermatitis questions can be answered.


Assuntos
Alérgenos/imunologia , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/imunologia , Testes do Emplastro , Gerenciamento Clínico , Humanos , Testes do Emplastro/métodos , Seleção de Pacientes
2.
Am J Phys Med Rehabil ; 89(2): 153-5, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19884811

RESUMO

Keloids are associated with small-fiber neuropathy and typically present with itching, pain, and allodynia. The following is a case presentation in which painful neuropathic symptoms from a keloid were treated successfully with botulinum toxin type A. To our knowledge, this is the first such case report in the literature. Further research in the use of botulinum toxin to treat keloidal pain is warranted.


Assuntos
Toxinas Botulínicas Tipo A/uso terapêutico , Queloide/complicações , Fármacos Neuromusculares/uso terapêutico , Dor/tratamento farmacológico , Dor/etiologia , Idoso de 80 Anos ou mais , Feminino , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...